A Real-world Comparative Analysis of DPP-4 Inhibitors Versus SGLT2 Inhibitors in Type 2 Diabetes Mellitus
Pharmaceutical and Biomedical Research · 01.03.2026 · 12 (2) · 109-118
DOI: 10.32598/pbr.12.2.1450.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical and Biomedical Research, erschienen am 01.03.2026. Verfasst von Parth Patel und 4 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Patel, P., Patel, X., Patel, Z., Prajapati, A., & Patel, S. (2026). A Real-world Comparative Analysis of DPP-4 Inhibitors Versus SGLT2 Inhibitors in Type 2 Diabetes Mellitus. Pharmaceutical and Biomedical Research, 12(2), 109-118. https://doi.org/10.32598/pbr.12.2.1450.1
Vancouver
Patel P, Patel X, Patel Z, Prajapati A, Patel S. A Real-world Comparative Analysis of DPP-4 Inhibitors Versus SGLT2 Inhibitors in Type 2 Diabetes Mellitus. Pharmaceutical and Biomedical Research. 2026;12(2):109-118. doi:10.32598/pbr.12.2.1450.1
BibTeX
@article{Patel2026,
author = {Patel, Parth and Patel, Xama and Patel, Zankrut and Prajapati, Akanksha and Patel, Sumit},
title = {A Real-world Comparative Analysis of DPP-4 Inhibitors Versus SGLT2 Inhibitors in Type 2 Diabetes Mellitus},
journal = {Pharmaceutical and Biomedical Research},
year = {2026},
volume = {12},
number = {2},
pages = {109--118},
doi = {10.32598/pbr.12.2.1450.1}
}
EUVIMED